CTOs on the Move

Economic Development Commission of Florida's Spa

www.spacecoastedc.org

 
Economic Development Commission of Florida's Space Coast is a Rockledge, FL-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Gp Designs

Gp Designs is a Glen Ridge, NJ-based company in the Business Services sector.

Dropzone AI

Dropzone AI is the first AI SOC analyst that autonomously investigates alerts 24/7. It integrates with existing tools, adapts to your environment, and generates decision-ready reports. You can focus on real threats and 10X your team without adding headcount. No playbooks, code, or prompts required.

TBNG Consulting

TBNG Consulting puts technology in terms you can understand…business terms. Our team of experts and certified engineers will solve your daily IT problems and help you increase your productivity, lower operating costs, and secure your network to optimize your business or organization. We are an authorized partner with the most reputable and forward thinking hardware and software vendors and the only IT solutions that we provide for our clients are the IT solutions that we use for our own company. TBNG Consulting knows that customer service is the cornerstone of good business and we will provide your organization a custom, scalable, and flexible technology solution that meets your current needs and address your future concerns.

Radon Away

Radon Away is a Haverhill, MA-based company in the Business Services sector.

Ensho Therapeutics

Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.